Document is current

Article History

Received: 30 October 2023

Accepted: 17 December 2025

First Online: 30 December 2025

Declarations

:

: The study protocol, encompassing access to and utilization of patient clinical data, received approval from the Institutional Review Boards (IRBs) at An-Najah National University and local health authorities. The IRB approval reference is (Ref. Pharm. D, March 2022/19), ensuring the protection of individuals without any associated risks. This research adhered to the principles outlined in the Helsinki Declaration and European guidelines for good clinical practice. Additionally, approval was sought and obtained from the NNUH search center. We want to emphasize that the collected information was exclusively utilized for clinical research purposes, with all patient data treated as confidential. The participants were provided with informed consent forms that assured data privacy, and the collected data remained confidential and dedicated solely to research. All the information was securely stored in a locked cabinet to safeguard human body rights, with limited access granted only to the researcher. Notably, the IRB of An-Najah National University exclusively approved verbal consent, as participants were solely required for interviews and faced no harm, provided that their privacy was maintained. The authors confirm that all methods adhered to the relevant guidelines and regulations.

: Not applicable.

: The authors declare no competing interests.